Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04196595 · ClinicalTrials.gov registry record

Apple Women's Health Study

A clinical trial of Infertility and Menopause, sponsored by Apple.

Recruiting
Registry status
500,000
Enrollment target
1
Study location

NCT04196595 is a study of Infertility and Menopause that is actively recruiting participants, run by Apple. The registered enrollment target is 500,000 participants, above the 833-participant average among 74 other Infertility trials with a reported enrollment target (59924% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04196595, a study of Infertility and Menopause, is actively recruiting participants, sponsored by Apple.

RECRUITING
Registry status
500,000 participants
Enrollment target
1
Study location

Study Summary

This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate in Apple-supported health-related research studies.

Study Locations (1)

Massachusetts

  • Harvard T.H. Chan School of Public Health - Boston

Trial Details

FieldValue
Enrollment Target 500,000 participants
Start Date 2019-11-14
Est. Completion 2029-11

Sponsor

Apple

12 total trials

What the Registry Record Tells You About NCT04196595

The ClinicalTrials.gov registry entry for NCT04196595 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 833-participant average among 74 other Infertility trials with a reported enrollment target (59924% higher). The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT04196595 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04196595 about?

NCT04196595 is a clinical study titled "Apple Women's Health Study". This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate i...

What is the current status of trial NCT04196595?

This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2019-11-14. Estimated completion is 2029-11.

What conditions does trial NCT04196595 study?

This clinical trial studies the following conditions: Infertility, Menopause, Polycystic Ovary Syndrome, Reproductive Health, Menstrual Cycle.

Who is sponsoring clinical trial NCT04196595?

This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04196595 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.